Stevenage Bioscience Catalyst

Stevenage Bioscience Catalyst is a £38 million partnership between the Wellcome Trust, UK government, GlaxoSmithKline, the East of England Development Agency and the Technology Strategy Board, to develop a bioscience park adjacent to GSK's R&D facilities in Stevenage, Hertfordshire.

Pioneering a culture of open innovation, the park is designed to stimulate innovation in product development and accelerate the delivery of cutting-edge healthcare solutions.

This unique bioscience community will provide small biotech and life sciences companies with access to the expertise, networks and scientific facilities traditionally associated with multinational pharmaceutical companies. Tenants retain full independence and the freedom to interact with any commercial partners.

Hear from Martino Picardo, CEO of Stevenage Bioscience Catalyst.

Sorry, but you need Flash Player 8 or higher to view the media player Download Flash

Running time: 5 min 42 s

For more information about the park and potential tenancies, please see the Stevenage Bioscience Catalyst website.